Scientists dive deep into kidney tumor diversity in rare genetic condition
NCT ID NCT06195150
First seen May 16, 2026 · Last updated May 24, 2026 · Updated 2 times
Summary
This study aims to understand how kidney tumors differ from one another in people with von Hippel-Lindau (VHL) syndrome, a rare genetic condition. Researchers will use advanced imaging, multiple tumor biopsies, and lab-grown tumor models to map these differences. The goal is to learn more about the disease and test potential treatments in the lab, not to directly treat participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL RENAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
IRCCS Ospedale San Raffaele
Milan, MI, 20132, Italy
Conditions
Explore the condition pages connected to this study.